% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{ErdreichEpstein:119911,
author = {A. Erdreich-Epstein and N. Robison and X. Ren and H. Zhou
and J. Xu and T. B. Davidson and M. Schur and F. H. Gilles
and L. Ji and J. Malvar and G. M. Shackleford and A. S.
Margol and M. D. Krieger and A. R. Judkins and D. Jones$^*$
and S. Pfister$^*$ and M. Kool$^*$ and R. Sposto and S.
Asgharzadeh and S. Asgharazadeh},
title = {{PID}1 ({NYGGF}4), a new growth-inhibitory gene in
embryonal brain tumors and gliomas.},
journal = {Clinical cancer research},
volume = {20},
number = {4},
issn = {1557-3265},
address = {Philadelphia, Pa. [u.a.]},
publisher = {AACR},
reportid = {DKFZ-2017-00502},
pages = {827 - 836},
year = {2014},
abstract = {We present here the first report of PID1 (Phosphotyrosine
Interaction Domain containing 1; NYGGF4) in cancer. PID1 was
identified in 2006 as a gene that modulates insulin
signaling and mitochondrial function in adipocytes and
muscle cells.Using four independent medulloblastoma
datasets, we show that mean PID1 mRNA levels were lower in
unfavorable medulloblastomas (groups 3 and 4, and anaplastic
histology) compared with favorable medulloblastomas (SHH and
WNT groups, and desmoplastic/nodular histology) and with
fetal cerebellum. In two large independent glioma datasets,
PID1 mRNA was lower in glioblastomas (GBM), the most
malignant gliomas, compared with other astrocytomas,
oligodendrogliomas and nontumor brains. Neural and proneural
GBM subtypes had higher PID1 mRNA compared with classical
and mesenchymal GBM. Importantly, overall survival and
radiation-free progression-free survival were longer in
medulloblastoma patients whose tumors had higher PID1 mRNA
(univariate and multivariate analyses). Higher PID1 mRNA
also correlated with longer overall survival in patients
with glioma and GBM. In cell culture, overexpression of PID1
inhibited colony formation in medulloblastoma, atypical
teratoid rhabdoid tumor (ATRT), and GBM cell lines.
Increasing PID1 also increased cell death and apoptosis,
inhibited proliferation, induced mitochondrial
depolaization, and decreased serum-mediated phosphorylation
of AKT and ERK in medulloblastoma, ATRT, and/or GBM cell
lines, whereas siRNA to PID1 diminished mitochondrial
depolarization.These data are the first to link PID1 to
cancer and suggest that PID1 may have a tumor inhibitory
function in these pediatric and adult brain tumors.},
keywords = {Carrier Proteins (NLM Chemicals) / PID1 protein, human (NLM
Chemicals) / RNA, Messenger (NLM Chemicals)},
cin = {B062},
ddc = {610},
cid = {I:(DE-He78)B062-20160331},
pnm = {312 - Functional and structural genomics (POF3-312)},
pid = {G:(DE-HGF)POF3-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:24300787},
pmc = {pmc:PMC3962776},
doi = {10.1158/1078-0432.CCR-13-2053},
url = {https://inrepo02.dkfz.de/record/119911},
}